Kashiv BioSciences, LLC clinical trials
Acquired by Amneal Pharmaceuticals, Inc., Aug 10, 2026 · source ↗
The registry lists 9 studies whose lead sponsor is Kashiv BioSciences, LLC. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 12, 2026.
Before and after it joined Amneal Pharmaceuticals, Inc.
- First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.
- 9
- First submitted after Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Kashiv BioSciences, LLC9 studies
Something wrong with this grouping? Tell us on the Amneal Pharmaceuticals, Inc. page.
Studies
Recruiting first, then most recently updated. Showing 9 of 9. All Amneal Pharmaceuticals, Inc. studies →
- Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female VolunteersRecruitingNCT06995482Phase 1
Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.
- Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy SubjectsCompletedNCT06929039Phase 1
Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.
- A Comparative Evaluation of Pharmacokinetics and Immunogenicity.CompletedNCT06918587Phase 1
Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.
- A Comparative Pharmacokinetic Study of ADL-018 Autoinjector Compared to A Pre-filled Syringe in Healthy Subjects.CompletedNCT06929052Phase 1
Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.
- Pharmacokinetic, Immunogenicity, and Safety Evaluation of Pegfilgrastim TPI-120 in Healthy AdultsCompletedNCT07416955Phase 1
Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.
- Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic UrticariaCompletedNCT05774639Phase 3
Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.
- PK, PD, Safety & Immunogenicity of ADL-018 Lyo in Healthy Adult SubjectsCompletedNCT05564611Phase 1
Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.
- Open Label, Sequential Dosing , Single Ascending Dose and Multiple Dose Safety Tolerability and Pharmacokinetic StudyCompletedNCT06074757Phase 1
Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.
- To Compare the PK, PD, Safety & Immunogenicity of ADL-018 in Healthy SubjectsCompletedNCT05413161Phase 1
Sponsor listed in the registry: Kashiv BioSciences, LLC · First submitted before Kashiv BioSciences, LLC became part of Amneal Pharmaceuticals, Inc.